Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;34(2):138-142.
doi: 10.5114/ada.2017.67078. Epub 2017 Apr 13.

Comparison of the incidence of skin cancers in patients on dialysis and after kidney transplantation

Joanna Sułowicz  1 , Anna Wojas-Pelc  1 , Ewa Ignacak  2 , Katarzyna Krzanowska  2 , Marek Kuźniewski  2 , Władysław Sułowicz  2
Affiliations

Comparison of the incidence of skin cancers in patients on dialysis and after kidney transplantation

Joanna Sułowicz et al. Postepy Dermatol Alergol. 2017 Apr.

Abstract

Introduction: Kidney transplant (KTx) patients on immunosuppressive therapy are predisposed to the development of infections and cancers.

Aim: To compare the incidence and type of malignant skin lesions in kidney transplant patients and the dialyzed population based on the initiated dermatologic screening.

Material and methods: The study included 598 patients: 486 kidney transplant recipients and 112 patients on maintenance dialysis. All the patients underwent dermatological examination. Only histologically confirmed cancers were included in this study. Age, gender and immunosuppressive therapy administration were also considered. Patients were followed up by a dermatologist for a period of 5 years.

Results: Fifty-eight skin cancers; 39 basal cell carcinomas (BCC), 13 squamous cell carcinomas (SCC), 1 Bowen disease, 2 Kaposi sarcoma, 1 malignant melanoma, 1 Merkel cell carcinoma, and 1 fibrosarcoma protuberans were diagnosed in 30 (6.2%) kidney transplant patients, and 8 lesions (7 BCC and 1 SCC) were found in 4 (3.6%) patients on dialysis.

Conclusions: The initiated dermatologic screening program indicates that the risk of skin cancer incidence in post kidney transplant patients receiving immunosuppressive therapy was significantly higher than in patients on dialysis.

Keywords: dialysis; immunosuppression; kidney transplantation; skin cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Rodriguez-Acosta ED, Calva-Mercado JJ, Alberú-Gómez J, et al. Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital. Gac Med Mex. 2015;151:20–6. - PubMed
    1. Tessari G, Naldi L, Boschiero L, et al. Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study. Am J Transplant. 2013;13:214–21. - PubMed
    1. Wisgerhof HC, van der Geest LG, de Fijter JW, et al. Incidence of cancer in kidney transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol. 2011;35:105–11. - PubMed
    1. Einollahi B, Nemeti E, Leksan-Pezeshki M, et al. Skin cancer after renal transplantation: results of a multicenter study in Iran. Ann Transplant. 2010;15:44–50. - PubMed
    1. Hwang JK, Moon IS, Kim JI. Malignancies after kidney transplantation: a 40-year single-center experience in Korea. Transpl Int. 2011;24:716–21. - PubMed